Avid Bioservices Inc (CDMO)

[eb0783]

So are you pointing out how much better they have done with their expenses than the average BP/biotech or are you trying to say that this is a terrible company?

This company has lost over one half billion and going strong

Because

BOSTON – Nov. 18, 2014 – Developing a new prescription medicine that gains marketing approval, a process often lasting longer than a decade, is estimated to cost $2,558 million, according to a new study by the Tufts Center for the Study of Drug Development.